These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28664672)

  • 1. Progression of an untreated pseudotumor.
    Iqbal M; Comp PC; Wu DH
    Haemophilia; 2017 Sep; 23(5):e464-e466. PubMed ID: 28664672
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimal lesion number for evaluation of tumor response in response evaluation criteria in solid tumors.
    Rosen MA; Sullivan D
    J Clin Oncol; 2010 Apr; 28(10):e159-60; author reply e161. PubMed ID: 20159810
    [No Abstract]   [Full Text] [Related]  

  • 3. PET scan in the therapeutic strategy.
    Haioun C; Itti E; Rahmouni A; Meignan M; Reyes F
    Hematol J; 2004; 5 Suppl 3():S149-53. PubMed ID: 15190298
    [No Abstract]   [Full Text] [Related]  

  • 4. Ultrasound techniques for the detection of tumors and metastases in small animals.
    Didié M; Zimmermann WH
    Methods Mol Biol; 2014; 1070():181-90. PubMed ID: 24092440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging to study solid tumour origin and progression: lessons from research and clinical oncology.
    Raimondo S; Zito G
    Immunol Cell Biol; 2017 Jul; 95(6):531-537. PubMed ID: 28294139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging the Tumor Microenvironment.
    LeBleu VS
    Cancer J; 2015; 21(3):174-8. PubMed ID: 26049696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mackenzie Davidson Memorial Lecture 1994: imaging of treated cancer.
    Husband JE
    Br J Radiol; 1995 Jan; 68(805):1-12. PubMed ID: 7881875
    [No Abstract]   [Full Text] [Related]  

  • 8. Feasibility of automated partial-volume correction of SUVs in current PET/CT scanners: can manufacturers provide integrated, ready-to-use software?
    Basu S; Alavi A
    J Nucl Med; 2008 Jun; 49(6):1031-2; author reply 1032-3. PubMed ID: 18483094
    [No Abstract]   [Full Text] [Related]  

  • 9. RECIST 1.1-Update and clarification: From the RECIST committee.
    Schwartz LH; Litière S; de Vries E; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; Seymour L
    Eur J Cancer; 2016 Jul; 62():132-7. PubMed ID: 27189322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From the Guest Editor: Illuminating Cancer In Vivo With Molecular Imaging.
    Piwnica-Worms D
    Cancer J; 2015; 21(3):150-1. PubMed ID: 26049693
    [No Abstract]   [Full Text] [Related]  

  • 11. PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue sarcoma.
    Fendler WP; Lehmann M; Todica A; Herrmann K; Knösel T; Angele MK; Dürr HR; Rauch J; Bartenstein P; Cyran CC; Hacker M; Lindner LH
    J Nucl Med; 2015 Apr; 56(4):530-7. PubMed ID: 25722445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary. Are current tumour response criteria relevant for the 21st century?
    Padhani AR; Husband JE
    Br J Radiol; 2000 Oct; 73(874):1031-3. PubMed ID: 11271893
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic imaging in the assessment of the therapeutic response in oncology].
    Ferrozzi F; Ganzetti A; Campani R
    Radiol Med; 1999; 97(1-2):8-18. PubMed ID: 10319094
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor transport physiology: implications for imaging and imaging-guided therapy.
    Kuszyk BS; Corl FM; Franano FN; Bluemke DA; Hofmann LV; Fortman BJ; Fishman EK
    AJR Am J Roentgenol; 2001 Oct; 177(4):747-53. PubMed ID: 11566666
    [No Abstract]   [Full Text] [Related]  

  • 15. A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.
    Divine MR; Katiyar P; Kohlhofer U; Quintanilla-Martinez L; Pichler BJ; Disselhorst JA
    J Nucl Med; 2016 Mar; 57(3):473-9. PubMed ID: 26659350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting Secreted Luciferases to Monitor Tumor Progression In Vivo.
    Falcone L; Casucci M
    Methods Mol Biol; 2016; 1393():105-11. PubMed ID: 27033220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in elasticity imaging.
    Gheonea DI; Saftoiu A
    Ultraschall Med; 2010 Oct; 31(5):525-7. PubMed ID: 20922607
    [No Abstract]   [Full Text] [Related]  

  • 18. [Advantages of volume perfusion CT for evaluating the response of solid tumors to treatment with sunitinib].
    Horger M; Wiesinger B; Kopp HG; Ioanoviciu SD; Bitzer M; Spira D; Schulze M
    Rofo; 2013 Jul; 185(7):595-602. PubMed ID: 23804124
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo mathematical modeling of tumor growth from imaging data: soon to come in the future?
    Cornelis F; Saut O; Cumsille P; Lombardi D; Iollo A; Palussiere J; Colin T
    Diagn Interv Imaging; 2013 Jun; 94(6):593-600. PubMed ID: 23582413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging concepts in tumor progression and therapy.
    Classon M; Settleman J
    Semin Cancer Biol; 2000 Dec; 10(6):393-7. PubMed ID: 11170861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.